Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis

Summary

To proof the superiority of an 8-week rectal treatment with once-daily 2 mg budesonide versus placebo for the prevention of acute radiation proctitis, and to evaluate the occurrence of chronic radiation proctitis 1 year after start of radiation therapy.

Timeline

Start

2008-09

Primary completion

2011-08

Completion

2011-10

Drugs

Indications